Contract analysis
Clause-by-clause risk read on any document of the firm. Pick a contract, or open any document from a matter.
Contract analysis / funds-flow-memo-revised.xlsx
funds-flow-memo-revised.xlsx
High · 1
Medium · 0
Standard · 0
[sheet: Cover & Summary]
High
⚑ Indemnity / guarantee obligation
[sheet: Cover & Summary] Field | Detail Document Title | Funds Flow Memorandum — Revised Draft Date | July 2, 2024 Prepared By | Calderwood & Harkness LLP Matter Number | 1018-00008 Lead Associate | Megan Chu Reviewed By | Oliver Mackenzie, Partner Transaction | Acquisition of 100% of Outstanding Capital Stock of Veridian Biosciences, Inc. by Penterra Pharmaceuticals Corp. Governing Agreement | Stock Purchase Agreeme